(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics >  Cancer
 
 Cancer Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  9  10  Next »
World Cancer Diagnostic Technologies and Emerging Markets 2014

This unique 1,200-page report contains 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country.  Available by country and section....

 

$32500.00
       
Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the U....

 

$32500.00
       
Future Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies

The report provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country. Available by country and section....

 

$28500.00
       
Innovative Cancer Diagnostic Technologies and Emerging Markets

This unique 1,200-page report contains 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country. Available by country and section.

 

$28500.00
       
Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

“Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence” is Venture Planning Group’s new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U....

 

$24500.00
       
Cancer Diagnostic Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for Current and Emerging Tumor Markers France, Germany, Italy, Japan, Spain, UK, US

This DataPack contain 450 tables from Venture Planning Group new 7-country study, “Competing in the Global Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

 

$21100.00
       
Competing in the European Cancer Diagnostics Market:
France, Germany, Italy, Spain, UK


This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.



 

$19700.00
       
Cancer Testing in Europe: Market Segment Forecasts and Supplier Shares

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.

This comprehensive five-country report identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....


 

$19700.00
       
2014 Opportunities in the European Cancer Diagnostics Market

“2014 Opportunities in the European Cancer Diagnostics Market” is a new five-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$19700.00
       
2014 Analysis of the European Cancer Diagnostics Market:
France, Germany, Italy, Spain, UK--Sales Forecasts, Supplier Shares, Competitive Strategies


“2014 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK Sales Forecasts, Supplier Shares, Competitive Strategies” is a new five-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$19700.00
       
European Cancer Diagnostics Market 2014:
France, Germany, Italy, Spain, UK
Sales Forecasts, Supplier Shares, Competitive Strategies


“European Cancer Diagnostics Market 2014: France, Germany, Italy, Spain, UK Sales Forecasts, Supplier Shares, Competitive Strategies” is a new five-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$19700.00
       
New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

“New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in major European countries; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

 

$19700.00
       
2015 European Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....

 

$19700.00
       
2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

“2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations” is Venture Planning Group’s new study of the major business opportunities emerging in the European cancer diagnostics market during the next five years....


 

$19700.00
       
Future Horizons and Growth Strategies in the European Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new five-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$19700.00
       
2014-2018 European Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

Summary

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....


 

$19700.00
       
2016 European Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Supplier Shares, Country Segment Forecasts, Competitive Strategies

Summary

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....


 

$19700.00
       
2016 New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

“2016 New Frontiers in the European Cancer Diagnostics Market” is VPGMarketResearch’s new study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in major European countries; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

 

$19700.00
       
« Previous     1  2  3  4  5  6  7  8  9  10   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X